Literature DB >> 13576231

Some observations on the incidence of pre-eclampsia.

I MACGILLIVRAY.   

Abstract

Keywords:  ECLAMPSIA/statistics

Mesh：

Year:  1958        PMID： 13576231     DOI： 10.1111/j.1471-0528.1958.tb08557.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Br Emp        ISSN： 0307-1871


× No keyword cloud information.
  9 in total

1.  Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study.

Authors:  Daniel M Green; Jane M Lange; Eve M Peabody; Natalia N Grigorieva; Susan M Peterson; John A Kalapurakal; Norman E Breslow
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa.

Authors:  Elizabeth W Triche; Karisa K Harland; Elizabeth H Field; Linda M Rubenstein; Audrey F Saftlas
Journal:  J Reprod Immunol       Date:  2013-08-06       Impact factor: 4.054

3.  An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance.

Authors:  C Hayward; J Livingstone; S Holloway; W A Liston; D J Brock
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

Review 4.  Preeclampsia. Still an enigma.

Authors:  J Duda
Journal:  West J Med       Date:  1996-04

5.  Fetal and maternal contributions to risk of pre-eclampsia: population based study.

Authors:  R T Lie; S Rasmussen; H Brunborg; H K Gjessing; E Lie-Nielsen; L M Irgens
Journal:  BMJ       Date:  1998-05-02

6.  Body weight in parous women.

Authors:  W Z Billewicz
Journal:  Br J Prev Soc Med       Date:  1970-05

7.  Genetic control of severe pre-eclampsia.

Authors:  D W Cooper; W A Liston
Journal:  J Med Genet       Date:  1979-12       Impact factor: 6.318

8.  Case-control study of severe pre-eclampsia of early onset.

Authors:  M P Moore; C W Redman
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-27

9.  Maternal cell-mediated immunity in normal and pre-eclamptic pregnancy.

Authors:  I L Sargent; C W Redman; G M Stirrat
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.